Rival puts AstraZeneca under pressure

Pharmaceuticals giant AstraZeneca saw its share price fall 2% today after a rival applied to make a copycat version of its key ulcer treatment.

Rival puts AstraZeneca under pressure

Pharmaceuticals giant AstraZeneca saw its share price fall 2% today after a rival applied to make a copycat version of its key ulcer treatment.

Astra said Ranbaxy Laboratories, based in India, had filed an application to the US authorities to create a rival to Nexium, used to treat stomach ulcers and heartburn.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited